Problem: To assess the efficacy of budesonide intrapolyp injection in chronic rhinosinusitis with nasal polyps.
Method: Ninety patients were divided into three groups; group A was given oral prednisolone, group B was given budesonide intrapolyp injection weekly for five consecutive weeks and group C was given budesonide as nasal irrigation for one month. Patients were assessed using Sino-Nasal Outcome Test 22 score, total nasal polyp score, serum immunoglobulin E, absolute eosinophilic count, and morning cortisol level before treatment, one week and three months after completing their treatment.
Results: Total nasal polyp score decreased significantly in all groups compared to those at baseline. Reduction in the oral and injection groups was greater than the wash group (2 = 0.004), (3 < 0.001), and the same trend concerning Sino-Nasal Outcome Test 22 score (2 < 0.001), (3 < 0.001).
Conclusion: Budesonide is an effective agent used in intrapolyp injection with no documented systemic or visual side effects that has comparable results with oral steroids.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1017/S0022215123001688 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intrapolyp Steroid Injection for Nasal Polyposis: A Systematic Review and Network Meta-Analysis.
Laryngoscope
December 2024
Department of Otolaryngology-Head and Neck Surgery, Zain Hospital, Ministry of Health, Kuwait City, Kuwait.
Objective: To conduct a systematic review and network meta-analysis to evaluate the safety and efficacy of intrapolyp steroid injection compared with oral steroids, nasal steroid wash, nasal steroid spray, and a control group in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Data Sources: PubMed, Scopus, Web of Science, Embase, and CENTRAL.
Review Methods: Both randomized and non-randomized clinical trials were included.
The Efficacy of Budesonide as Intrapolyp Injection Agent in the Management of Type 2 CRSwNP.
Laryngoscope
May 2024
Otorhinolaryngology Department, Faculty of Medicine, Kafrelsheikh University, Kafr El-Shaikh, Egypt.
Article Synopsis
- The study aimed to evaluate the effectiveness and safety of budesonide, a steroid injection, for treating chronic rhinosinusitis with nasal polyps (CRSwNP) compared to oral steroids and a control group.
- In a randomized clinical trial with 150 patients, results showed that both budesonide and oral steroids significantly improved symptoms and nasal polyp scores, while the control group did not show significant improvement.
- The conclusion indicates that intrapolyp steroid injections, especially budesonide, are a safe and effective option for patients with recurrent nasal polyps, potentially reducing the need for systemic steroids.
The role of budesonide intrapolyp injection in the management of type 2 chronic rhinosinusitis with nasal polyps: a randomised clinical trial.
J Laryngol Otol
April 2024
Otorhinolaryngology Department, Faculty of Medicine - Kafrelsheikh University, Kafr ElSheikh, Egypt.
Problem: To assess the efficacy of budesonide intrapolyp injection in chronic rhinosinusitis with nasal polyps.
Method: Ninety patients were divided into three groups; group A was given oral prednisolone, group B was given budesonide intrapolyp injection weekly for five consecutive weeks and group C was given budesonide as nasal irrigation for one month. Patients were assessed using Sino-Nasal Outcome Test 22 score, total nasal polyp score, serum immunoglobulin E, absolute eosinophilic count, and morning cortisol level before treatment, one week and three months after completing their treatment.
Effects of intrapolyp steroid injection on intraocular pressure and recurrent polyp treatment.
Eye (Lond)
October 2022
Department of Ophthalmology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Purpose: To examine the effects of intrapolyp triamcinolone acetonide (TA) injections on intraocular pressure (IOP) and recurrence of nasal polyps after endoscopic sinus surgery.
Patients And Methods: This was a prospective, randomized, double-blind, placebo-controlled study. Patients were randomized into either the TA injection group (Group I, 20 mg/ml, 2 mL) or the placebo normal saline injection group (group II, 2 mL).
Injection of Steroid in Nasal Polyps: A Systematic Review.
Am J Rhinol Allergy
November 2020
Department of Otorhinolaryngology - Head and Neck Surgery and Audiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Background: Chronic rhinosinusitis (CRS) is a common chronic condition classically divided into two phenotypes according to the presence or absence of nasal polyps. The effects of both medical and surgical treatment are often temporary, encouraging research into new treatment options.
Methods: We performed a systematic review related to dosages, effects, side effects, and safety of intrapolyp steroid injection in patients with nasal polyps.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!